Consequences of Nonadherence in Hemophilia A

EP: 1.Management Insights for Patients With Hemophilia

EP: 2.Coverage Decisions for Expensive Hemophilia Treatments

EP: 3.Impact of ICER Reports on Hemophilia Treatment Decisions

EP: 4.Enhancing Provider Access and Expertise for Rare Disease Care

EP: 5.Factors Impacting Hemophilia A Care Costs

EP: 6.Collaborative Strategies in Hemophilia A Care Cost Management

EP: 7.Strategies to Manage Medication Costs and Waste

EP: 8.Adapting to Novel Hemophilia A Treatments

EP: 9.Comprehensive Insights into Hemophilia A: Prevalence, Clinical Impact, and Economic Considerations

EP: 10.Evolution of the Hemophilia A Treatment Landscape: Innovations and Guidelines

EP: 11.Hemophilia A Treatment Factors and Outcomes

EP: 12.Prophylactic Treatment Challenges and Considerations for Hemophilia A

Now Viewing

EP: 13.Consequences of Nonadherence in Hemophilia A

EP: 14.Advancements in Hemophilia A Therapies

EP: 15.Comparing Hemophilia A Therapies: Efficacy and Safety Insights

EP: 16.Real-World Insights: Factor vs Emicizumab in Hemophilia A

EP: 17.Emicizumab Dosing: Prophylaxis and Bleeding Management

EP: 18.Optimizing Hemophilia Treatment: Strategies and Adherence

EP: 19.Advancements in Hemophilia A Therapies: Altuviiio and Roctavian

EP: 20.Advancements in Hemophilia A Treatment: Fitusiran and the Evolving Landscape

This is a video synopsis/summary of an Insights involving Allison Wheeler, MD.

Wheeler discusses the consequences of nonadherence to prophylaxis treatment in hemophilia A, emphasizing the impact on joint health and immediate severe bleeding episodes. To enhance treatment compliance, she highlights the importance of tailored communication with patients, aligning discussions with their interests, such as sports or family planning. Collaborative efforts involve a dedicated health care team including subspecialty pharmacists, physical therapists, clinical nurses, social workers, and child life providers. This multidisciplinary approach monitors medication adherence, provides emotional support, and addresses nuanced aspects of patients’ lives. Wheeler underscores the critical role of effective communication, individualized strategies, and teamwork in optimizing outcomes for hemophilia A patients.

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.